secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001628280-25-020057
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics prices $2.35M public offering of common stock and warrants
--------------------------------------------------------------------------------

- 3,133,333 shares and two series of warrants priced at $0.75 per unit; gross proceeds ~$2.35M.
- Net proceeds of ~$1.9M after 7% placement agent fee and expenses.
- Series B-1 warrants ($0.85 exercise, 5-yr term) and B-2 warrants ($0.85, 18-mo term).
- Proceeds for INVINCIBLE-4 patient enrollment, INVINCIBLE-3 treatment, and working capital.
- Offering expected to close April 28, 2025; A.G.P. and Brookline Capital Markets as placement agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000162828025020057/0001628280-25-020057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000162828025020057/intensity-20250424.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-020057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer